Pfizer Under Pressure Amid Obesity Drug Bidding War

2 months ago

Critty Gupta

"A stock that's really taking a hit besides the airlines is going to be Fizer. PFE is your ticker there. Down about 1.8% and dropping as we speak. This comes after Nova Nordisk after the bell yesterday re-up their bid for Meter. It's unclear what the price is at the moment, but you are starting to see Fizer and Novo in this massive bidding war for the obesity drugs company. So, we will see if it gets there."

Pfizer (PFE) is experiencing pressure with stocks falling nearly 1.8% amid a competitive bidding war with Novo Nordisk for an obesity drug company, highlighting market uncertainty around its prospects.

Related Stocks